Top Stories News
Top Stories news
-
News US committee recommends approval of GSKs bird flu vaccine
A US health regulator has recommended the approval of GlaxoSmithKline's new bird flu vaccine. -
News World Diabetes Day: 14 November 2012
The European Medicines Agency supports World Diabetes Day, which is taking place on Wednesday 14 November 2012. -
News Sun Pharma to acquire DUSA Pharmaceuticals
Sun Pharma will acquire DUSA Pharmaceuticals in a deal worth approximately $230 million. -
News Boehringer Ingelheim to collaborate with Molecular Partners
Boehringer Ingelheim has entered into a manufacturing agreement with Molecular Partners -
News A completely new way of delivering anti-cancer drugs
A completely new way of delivering anti-cancer drugs to tumours, using 'minicells' derived from bacteria, has been tested for the first time in humans and found to be safe, well-tolerated and even induced stable disease in patients with advanced, incur... -
News Prostate cancer drug market 'worth $9.1bn by 2021'
Decision Resources' latest report looks at the prostate cancer drug market between now and 2021. -
News AMD and DR drug market to reach $6.25bn by 2015
There is a strong and growing market for drugs to treat the eye diseases AMD and DR, analysts say -
News Obama win keeps healthcare reforms at the forefront in US
Healthcare reforms will remain on the agenda in the US after Barrack Obama wins a second term as president. -
News Takeda to acquire Envoy Therapeutics
Takeda has announced the acquisition of Envoy Therapeutics for $140 million. -
News Claris Lifesciences announces joint venture in India and emerging markets
Claris, Otsuka Pharmaceutical and Mitsui have entered into a new joint venture. -
News WIN Consortium announces collaboration with Pfizer
The WIN Consortium has confirmed Pfizer as its first pharmaceutical partner. -
News Construction to begin on world's largest chromatography lab
Novasep intends to build the world's largest chromatography facility for pharmaceutical work. -
News Report recommends patient-centric approach to encourage adherence
Patient adherence to medication could be improved by adopting a more patient-centric approach, a report suggests. -
News UK spending on new medicines is falling
The head of the ABPI has expressed concern at the UK's falling expenditure on new medicines. -
News Watson sells Rugby OTC products and trademarks to Major Pharmaceuticals
Watson has sold its Rugby OTC product trademark and assets to the Harvard Drug Group. -
News Bayer set to buy Schiff Nutrition International for $1.2bn
Bayer has struck a deal to acquire US vitamin maker Schiff. -
News BioRx receives Zemaira distribution rights
BioRx has been added to the distribution network for Zemaira. -
News Celgene reports $1.4 billion of revenues for third quarter 2012
Celgene enjoyed healthy profits in the third quarter of 2012 -
News Sanofi to continue developing Prednisporin under sub-licencing agreement
Sanofi will continue development of Prednisporin, but expects to sub-licence the work to a third-party. -
News Organisational structure 'key to pharma compliance'
Pharmaceuticals have been told to centralise their compliance efforts for greater success. -
News Report reveals downward trend in US health R&D investment
There are concerns that the downward trend in R&D investment in the US could jeopardise the country's global competitiveness. -
News Charles River enters strategic partnership with AstraZeneca
Charles River Laboratories and AstraZeneca have reached a three-year agreement to deliver toxicology, safety pharmacology and development DMPK studies. -
News Forest and moksha8 form broad strategic alliance for Latin America
Forest Laboratories and moksha8 have announced a broad strategic alliance for Latin America. -
News Medicated chewing gum may prevent motion sickness
A team in Iran have produced a prototype gum with an acceptable taste that could help to deliver the motion sickness drug dimenhydrinate more rapidly. -
News 'Slight decline' in pharmaceutical M&A activity
A new report has highlighted a slight downward trend in mergers and acquisitions. -
News Global autologous cell therapy market worth $2.2bn by 2017
A number of autologous cell therapies are expected to reach the market by 2017, fuelling an impressive growth rate over the next few years. -
News Patent expiries 'pose challenge to enzyme inhibitor market growth'
A new TechNavio report has looked at the state of the global enzyme inhibitor market and its prospects for growth -
News Type-2 diabetes drug market set to double by 2021
The diabetes drug market is looking robust thanks to a large pipeline of new products and an ever-increasing patient population. -
News Australia may consider longer patent terms for medicines
The federal government in Australia has been urged to consider introducing longer patent terms for innovative medicines. -
News Capsugel ICSE/CPHI Booth #8F06
Expanded Finished Product Manufacturing Facilities Ready for Increased Licaps® Production -
News Medicia to distribute Injex 30 in Russia
A new distributor contract has been signed between Injex Pharma and Medicia. -
News New excipients on show at CPhl Worldwide in Madrid
New excipients will be on show at a pharmaceuticals event in Madrid later this month. -
News AMRI Announces Strategic Contract with Knopp Biosciences
SMARTSOURCING Agreement Strengthens Existing Relationship -
News BASF opens new topical formation lab in NY
BASF has announced the opening of a global dermatology lab in New York where topical formations will be developed for the pharmaceutical market. -
News Brazil delays new rules for governing excipients
Brazil's national medicines regulator has pushed back the implementation of proposed new rules that would govern the manufacturing of excipients. -
News PANREAC presents a new line of excipients for the pharmaceutical industry according to the IPEC guide
PANREAC specialized in the manufacturing of reagents for laboratory analysis, excipients and bulk chemicals to be used as raw materials in the pharmaceutical, cosmetic and food industries. -
News Panreac presents its synthesis product line
Panreac Synthesis is the business unit of PANREAC, the Spanish leader company in manufacturing reagents, solvents and fine chemicals since 1941. -
News Big pharma collaborate to speed up drug development
TransCelerate BioPharma is a non-profit organisation set up by ten biopharmaceutical giants. -
News Cardiolynx Receives Patent on Improved Angina Pectoris Drug
Cardiolynx Ltd., specializing in the development of improved cardio-metabolic therapies, announces that the European Patent Office (EPO) has granted a patent covering a new chemical entity, CLC-1280, developed using Cardiolynx' nitric oxide technology. -
News Mucosis Appoints Thomas Johnston to CEO
Mucosis B.V., the Dutch clinical-stage biotechnology company developing mucosal vaccines, today announced the appointment of Thomas Johnston to the position of Chief Executive Officer, effective immediately. -
News RepliGen Europe Limited withdraws its marketing authorisation application for SecreFlo (secretin human)
The European Medicines Agency has been formally notified by RepliGen Europe Limited of its decision to withdraw its application for a centralised marketing authorisation for the medicine SecreFlo (secretin human). -
News Committee for Orphan Medicinal Products elects new chair and vice-chair
At its September 2012 meeting, the European Medicines Agency's Committee for Orphan Medicinal Products (COMP) elected Professor Bruno Sepodes from Portugal as its chair and Ms Lesley Greene, a volunteer patient representative for Eurordis, as its vice-... -
News European Medicines Agency clarifies rules on fees
The European Medicines Agency has revised the rules on fees payable to the Agency. -
News Stella Blackburn appointed president of the International Society for Pharmacoepidemiology
The European Medicines Agency congratulates Dr Stella Blackburn, the Agency's Risk Management Development and Scientific Lead, for her appointment as president of the International Society for Pharmacoepidemiology (ISPE). -
News Pharmacovigilance Risk Assessment Committee (PRAC) elects chair and vice-chair
The European Medicines Agencys recently established Pharmacovigilance Risk Assessment Committee (PRAC) has elected June Raine (pictured) from the United Kingdom (UK) as its chair and álmath Spooner from Ireland as its vice-chair at its second mee... -
News Big Pharma Fights Drug Rulings In India
Landmark drug patent protection cases involving Bayer, Roche, and Novartis are advancing in India this month. Together, they will help determine how friendly the country is to Western pharmaceutical makers. -
News AESICA ANNOUNCES KEY NORTH AMERICAN APPOINTMENT
One of Europes leading CMOs, Aesica, has announced a key addition to its commercial team as it looks to strengthen its position in North America. -
News Possible therapy for tamoxifen-resistant breast cancer identified
A study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has discovered how tamoxifen-resistant breast-cancer cells grow and proliferate. -
News Pfizer leukaemia drug receives US approval
The US Food and Drug Administration has approved Pfizer's Bosulif, used to treat a rare type of leukaemia usually suffered by older adults. -
News FDA questions efficacy of Novartis cystic fibrosis drug tobramycin
The US Food and Drug Administration has questioned the efficacy of Novartis' experimental cystic fibrosis drug tobramycin ahead of an advisory panel meeting this week. -
News Biotage Unveils New Fully Automated Microwave Peptide Synthesizer
Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, introduced an innovative new synthesis platform for peptide researchers at the 2012 European Peptide Symposium in Athens, Greece... -
News Majority of pharma firms have in-house companion diagnostics staff
Many companies now have people working full-time on companion diagnostics for use alongside targeted therapies. -
News Pfizer and Mylan announce generics collaboration in Japan
A new partnership between Pfizer and Mylan should help to drive generic utilisation in Japan. -
News Pharma companies spend over $30m on global MSL teams
Cutting Edge Information has shed light on pharmaceutical companies' MSL spend. -
News Peru's Pharmaceutical Exports to Exceed $50M in 2012
The president of Peru's pharmaceutical industry association has predicted that exports will surpass $50 million this year. -
News Generics Save Consumers Billions of Pounds
Consumers and national healthcare systems make significant savings as a result of generic medicines usage, a report has confirmed. -
News Saladax Expands Relationship with BMS
Saladax Biomedical has expanded its existing relationship with Bristol-Myers Squibb by entering into a Master Early Development Collaboration Agreement. -
News Gilead to Collaborate with Indian Partners on Generic Versions of Emtricitabine
Gilead and its partners in India aim to improve access to affordable antiretroviral therapy for HIV patients in developing countries. -
News Study Says Generic Medications Saved $1 Trillion over the Last Decade
The American health care system saved more than $1 trillion through the use of generic medicines over the last decade. -
News Patent Expirations Hit Irish Pharma Exports to US
The end of patent protection has hit Irish pharmaceutical exports to the US in the first half of the year, new figures show. -
News Suzhou Connect Enters Licensing Agreement with Arena
Suzhou Connect hopes to advance novel small molecule compounds for the treatment of allergic rhinitis and atopic dermatitis. -
News Merck Serono Announces Creation of Prexton
The newly founded company will develop the mGluR programs from lead optimization up to clinical Phase I and seek partnership and licensing opportunities for further development. -
News 'Organs-on-chips' to Accelerate Drug Candidate Assessment
Harvard scientists hope to develop a unique instrument that will help drug developers to assess new drug candidates. -
News Pharma Industry Has 'Significant Pipeline' of New Obesity Treatments
Many leading pharmaceutical companies are working on new treatments for obesity and diabetes, according to a new Medmeme report. -
News Majority of Pharmaceutical Companies 'Worried about Disaster Recovery'
Health and pharmaceutical companies need to pay more attention to their backup and disaster recovery plans, a survey suggests. -
News Merck Signs Deals for Novel HIV Drug Candidates
Merck has signed licensing agreements with Chimerix Inc and Yamasa Corporation for two investigational HIV drug candidates. -
News Global Pharmaceutical Industry Calls for Cooperation on Counterfeit Medicines
Global industry groups have teamed up to tackle the serious problem of counterfeiting. -
News US Health Secretary Announces New Public-private Partnerships to Fight HIV/Aids
Kathleen Sebelius said a collective response from both public and private organisations is needed to fight the HIV/Aids epidemic. -
News RegeneRx And Lee's Reach License Agreement for TB4-based Products
RegeneRx and Lee's Pharmaceuticals have announced a licensing agreement for RegeneRx's TB4-based products in China (including Hong Kong and Macau) and Taiwan. -
News Report Shows Strong M&A Activity for Healthcare IT Sector
M&A activity in the healthcare and pharmaceutical IT sector is robust, according to Berkery Noyes. -
News Investment in eClinical Trial Solutions Could Improve Efficiency, Report Says
GBI Research predicts an increase in demand for eClinical trial solutions over the coming years, with a particular focus on electronic data capture. -
News TPG Set to Buy Par Pharmaceuticals
Generic drug maker Par Pharmaceuticals has agreed to be bought for $1.9 billion by TPG. -
News BMS to Expand Puerto Rican Site
Bristol-Myers Squibb is expanding its Humacao facility in order to manufacture additional medicines on the island of Puerto Rico. -
News Global Medicines Spend to Reach Nearly $1.2Tr in 2016
The IMS Institute for Healthcare Informatics forecasts 5-7 per cent growth in the global market in 2016. -
News Takeda & Affymax Announce Supply Agreement
The agreement allows Fresenius Medical Care North America to purchase OMONTYS for use in U.S. centers within its organization and provides for discounts and rebates on the product, subject to certain requirements. -
News BMS Begins Tender Offer to Acquire US Biotech Amylin
Bristol-Myers Squibb is commencing a tender offer to acquire all outstanding shares of common stock in Amylin Pharmaceuticals. -
News Pharma Companies Team up with Academic Institutions for TB Drug Discovery
The TBDA partnership aims to produce new clinical drug candidates with the potential to treat TB within a month. -
News Quintiles Launches Go-to-market Service for Biopharma
Allume will help biopharmaceutical companies to bring their products to market more quickly and efficiently. -
News Swiss Manufacturer Siegfried Plans Production Plant in China
Siegfried plans to open a new production plant in Nantong, China. -
News Pfizer Accused of Delaying Generic Versions of Lipitor
Pfizer is being sued by five retailers over its alleged actions to delay sales of generic versions of Lipitor. -
News Indian Generics Policy Is Bad News for Big Pharma
Pharmaceutical giants will suffer as a result of India's decision to hand out free generic medicines to its entire population. -
News Amgen Completes Acquisition of KAI Pharmaceuticals
Amgen has announced the completion of the acquisition of KAI Pharmaceuticals. -
News Medunik Canada & Orphan Europe Ink Deal
Under the distribution agreement, Medunik Canada receives the exclusive Canadian rights to market and distribute four important therapies. -
News Pharma Marketers Embracing Social Media
Websites such as Facebook and Twitter are increasingly being used by direct-to-consumer pharmaceutical marketing companies in markets where this type of advertising is allowed. -
News AstraZeneca Teams up with Cellworks to Find New TB Treatment
AstraZeneca and Cellworks have announced a Wellcome Trust-supported collaboration to speed up the design of new combination therapies for multi drug resistant TB. -
News HGS Rejects GSK Extension of Unsolicited Tender Offer
Human Genome Sciences has rejected GlaxoSmithKline's latest extension to its tender offer. -
News Bristol-Myers to Buy Diabetes Drug Maker Amylin for $5.3Bn
Bristol-Myers Squibb and Amylin Pharmaceuticals have announced that the global biopharmaceutical giant is set to acquire the diabetes drug maker for approximately $5.3 billion. -
News Argentina Proving Popular with CROs
A report by GBI Research has highlighted Argentina's increasing popularity as a cost-effective yet high-quality place to conduct clinical trials. -
News Scientists Find Easier Way to Make New Drug Compounds
Bristol Myers Squibb will employ a novel technique to develop and manufacture drugs. -
News Selvita & Orion Pharma Achieve a Research Milestone in Alzheimers Disease Program
Selvita is responsible for the discovery and Orion is responsible for the development and global commercialization. -
News Merck And AstraZeneca Amend Partnership, Agree Terms for Two More Years
Merck and AstraZeneca have amended their US partnership, giving the latter a 2014 buyout option. -
News 5 Minutes with Hao Gao, Scientist, R&D, Dow Wolff Cellulosics
Hao Gao, scientist, R&D, Dow Wolff Cellulosics, believes that customers seek new technologies and designer solutions for a competitive edge and his company is committed to delivering these kinds of tailored solutions. -
News FDA Approval of Generic ADHD Drug Hits Shire Shares
Actavis has received FDA approval for its generic version of Shire's Adderall XR, causing shares in the British drugmaker to plummet. -
News TaiGen & ZMC Sign Agreement for Antibiotic Nemonoxacin
TaiGen Biotechnology and Zhejiang Medicine Company have agreed terms for the broad-spectrum antibiotic nemonoxacin. -
News BRIC Markets Account for 20-30Pc of Pharma Companies' Profits
Cegedim's latest report highlights strategies to boost growth in China and other emerging markets. -
News Sales in China's Pharmaceutical Distribution Industry up 23Pc
China's Ministry of Commerce has published the latest figures on pharmaceutical distribution industry sales. -
News Quintiles to Establish HQ And Expand Lab Testing Capabilities in China
Quintiles is investing $14m in a new regional headquarters in Shanghai, as well as expanding its lab testing capabilities in China. -
News AstraZeneca Completes Ardea Merger
AstraZeneca has completed its takeover of biotechnology company Ardea Biosciences. -
News CellCentric & ZoBio Enter into Partnership to Develop Lead Compounds against Epigenetic Drug Targets
ZoBio will use its proprietary TINS technology to screen its fragment library against targets nominated by CellCentric. -
News Joint Call for Action to Alleviate Drug Shortages
An international collaboration is seeking to address drug shortages for patients with blood disorders. -
News Valeant Buys Oral Health Specialist OraPharma
Canadian drug maker Valeant has announced the acquisition of OraPharma. -
News Takeda to Cease Distribution of Pfizer Products in Japan
Takeda is to stop selling 13 Pfizer Inc drugs in Japan. -
News Small to Mid-sized Pharma Companies 'Turning to Cloud CRM Systems'
Cloud-based CRM systems offer smaller pharmaceutical companies a fast and cost-effective solution. -
News Human Genome Sciences Sets Bid Date of July 16th
Interested bidders have until July 16th to submit definitive proposals to acquire Human Genome Sciences. -
News OTC Pharmaceuticals Market to Reach $80.7Bn in 2014
The world market for over-the-counter (OTC) medicines will reach $80.7 billion in 2014, according to a new report from Visiongain. -
News Lilly Expands Partnership with Chinese Drugmaker Novast
Eli Lilly is increasing its investment in Chinese pharmaceutical company Novast Laboratories. -
News Cobra & Alligator Form Alliance for Monoclonal Antibody
Cobra Biologics and Alligator Bioscience have signed a manufacturing services and supply agreement for the production of monoclonal antibody drug product. -
News Anderson & Brecon Form Global Pharmaceutical Packaging Company
AndersonBrecon will provide packaging solutions for the pharmaceutical industry from 12 facilities across two continents. -
News Spectrum Pharmaceuticals Extends Tender Offer Period for Allos Therapeutics Shares
Spectrum and Allos have announced a further extension to the tender offer period for shares of Allos Therapeutics. -
News Public-private partnership aims to develop sustainable pharmaceuticals
A new research hub aims to develop sustainable alternatives to the finite materials used during pharmaceuticals manufacturing. -
News Bausch + Lomb Bolsters Product Portfolio with ISTA Acquisition
Bausch + Lomb has completed its acquisition of ISTA Pharmaceuticals. -
News Mexican Pharma Companies Represent Second-biggest Manufacturing Sector
Mexico is becoming an increasingly important emerging market for global pharmaceutical firms, according to research conducted by industry chamber Canifarma. -
News Fundación MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals
The alliance will be focused on complementing Cubists drug discovery programs with new lead compounds in the development of new anti-bacterial drugs. -
News GSK Extends Tender Offer for HGS
Human Genome Sciences has once again rejected GSK's unsolicited tender offer after the UK-based pharmaceutical group extended the deadline until June 29th. -
News UK Pharma Chief Expresses Concerns for Future of Medical Research
The chief executive of the ABPI has voiced fears about the UK government's focus on 'breakthrough' drug research. -
News OncoSec & VGXI Enter into Immunotherapy Drug Agreement
OncoSec Medical has chosen VGXI Inc as its manufacturing partner for DNA IL-12. -
News Dr Reddy's And Merck Announce Biosimilars Collaboration
Dr Reddy's Laboratories and Merck Serono will work together to develop cheaper versions of cancer biologics. -
News Takeda Completes Acquisition of URL Pharma
Takeda's wholly owned subsidiary, Takeda America Holdings, Inc., has completed its acquisition of URL Pharma, Inc. for an upfront payment of $800 million. -
News ShangPharma & Eli Lilly Celebrate 10 Years of Partnership
ShangPharma Corporation has celebrated the 10th anniversary of its partnership with Eli Lilly and Company. -
News US Has Nearly 1,000 Anti-cancer Medicines in Development
A new report highlights the efforts of biopharmaceutical companies to fight cancer.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance